THE IMPORTANCE OF CHROMOGRANIN A DOSAGE IN NEUROENDOCRINE TUMOURS

被引：0
作者：
Miric, Alexandra [1 ]
Papacocea, Raluca [1 ]
Paun, Diana [1 ]
Sima, Romina [1 ]
Voinea, Oana [1 ]
Anca, Ioana [1 ]
机构：
[1] Carol Davila Univ Med & Pharm, Bucharest, Romania
来源：
FARMACIA | 2023年 / 71卷 / 04期
关键词：
Neuroendocrine tumours; Chromogranin A; NEURON-SPECIFIC ENOLASE; CLINICAL UTILITY; MIBG SCINTIGRAPHY; FOLLOW-UP; DIAGNOSIS; MARKER; MANAGEMENT; PHEOCHROMOCYTOMA; NEOPLASIA; THERAPY;
D O I：
10.31925/farmacia.2023.4.14
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Neuroendocrine tumours are very rare clinical entities that result from tumour proliferation of neuroendocrine cells found in almost all organs of the body. Chromogranin A can be used in biochemical diagnosis as a neuroendocrine marker. Our study will highlight the importance of chromogranin A dosage in 3 groups of study of neuroendocrine tumours (pheochromocytomas, paragangliomas and gastroenteropancreatic NETs) compared to 3 groups of control (healthy control group, control group with non-secreting adrenal tumours and control group with non-endocrine digestive adenocarcinomas). In conclusion, the dynamics of pre-and postoperative CgA values showed statistically significant variations for the 3 groups of study.
引用
收藏
页码：781 / 787
页数：7
相关论文
共 55 条
[1]   Gastrointestinal neuroendocrine tumors in 2020 [J].
Ahmed, Monjur .
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 12 (08) :791-807
[2]   Plasma chromogranin A in incidental non-functioning, benign, solid adrenocortical tumors [J].
Bernini, G ;
Moretti, A ;
Fontana, V ;
Orlandini, C ;
Miccoli, P ;
Berti, P ;
Basolo, F ;
Faviana, P ;
Bardini, M ;
Salvetti, A .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 151 (02) :215-222
[3]   A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours [J].
Bernini, GP ;
Moretti, A ;
Ferdeghini, M ;
Ricci, S ;
Letizia, C ;
D'Erasmo, E ;
Argenio, GF ;
Salvetti, A .
BRITISH JOURNAL OF CANCER, 2001, 84 (05) :636-642
[4]   Chromogranin A, a member of neuroendocrine secretory proteins as a selective marker for laboratory diagnosis of pheochromocytoma [J].
Bilek, R. ;
Safarik, L. ;
Ciprova, V. ;
Vlcek, P. ;
Lisa, L. .
PHYSIOLOGICAL RESEARCH, 2008, 57 :S171-S179
[5]   Chromogranin A in the Laboratory Diagnosis of Pheochromocytoma and Paraganglioma [J].
Bilek, Radovan ;
Vlcek, Petr ;
Safarik, Libor ;
Michalsky, David ;
Novak, Kvetoslav ;
Duskova, Jaroslava ;
Vaclavikova, Eliska ;
Widimsky, Jiri, Jr. ;
Zelinka, Tomas .
CANCERS, 2019, 11 (04)
[6]   Chromogranin A: Is it a useful marker of neuroendocrine tumors? [J].
Campana, Davide ;
Nori, Francesca ;
Piscitelli, Lidya ;
Morselli-Labate, Antonio Maria ;
Pezzilli, Raffaele ;
Corinaldesi, Roberto ;
Tomassetti, Paola .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (15) :1967-1973
[7]  
d'Herbomez M, 2001, J NUCL MED, V42, P993
[8]   Update on the risks of benign adrenocortical incidentalomas [J].
Di Dalmazi, Guido .
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2017, 24 (03) :193-199
[9]   Significance of plasma chromogranin A determination in neuroendocrine tumour (NET) diagnosis [J].
Donica, H. ;
Malecha-Jedraszek, A. ;
Stroslawska, E. ;
Burska, A. ;
Szubstarski, F. .
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2010, 48 (04) :603-610
[10]  
Farrugia Frederick-Anthony, 2019, Endocr Regul, V53, P191, DOI 10.2478/enr-2019-0020
123456